We are happy to announce that Tom Shepherd, Ph.D. has been appointed as Captor Therapeutics' Chief Business Officer (CBO).

Tom Shepherd received a Ph.D. in biochemistry from the University of Strathclyde, Glasgow and completed an executive programme at London Business School. Prior to joining Captor, Dr. Shepherd held senior management or CEO positions on three continents, helping life sciences companies to define strategies linking science and business objectives.

Share: